|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02552 HUA MEDICINE-B
Nominal 
2.560 -0.030 (-1.158%) | 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/12 RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | |
| Turnover | 378,904 | 74.263% | 492,934 | 255,892 | 76,610 | 17,599 |
| Cost of Sales | (144,594) | 45.156% | (212,579) | (131,168) | (39,236) | (9,910) |
| Gross Profit | 234,310 | 98.873% | 280,355 | 124,724 | 37,374 | 7,689 |
| 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/12 RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 0 | -- | 0 | 0 | 0 | 0 | |
| Profit / (Loss) before Taxation | (30,195) | -- | 1,106,353 | (250,144) | (211,234) | (203,507) | |
| Taxation | 0 | -- | 0 | 0 | 0 | 0 | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 0 | -- | 0 | 0 | 0 | 0 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | (30,195) | -- | 1,106,353 | (250,144) | (211,234) | (203,507) | |
| 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/12 RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | |
| Net Finance Costs / (Income) | 720 | -- | (3,341) | (4,829) | (8,605) | (573) |
| Depreciation & Amortisation | 12,258 | -27.983% | 32,468 | 34,583 | 36,238 | 31,777 |
| Directors' Emoluments | -- | -- | 27,333 | 27,394 | 25,995 | 30,955 |
| 2026/06 - Interim | %Chg (Compare to Interim) | 2025/12 | 2024/12 | 2023/12 | 2022/12 | |
| Auditor's Opinion Status | N/A | -- | Unqualified | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2026/06 - Interim | %Chg (Compare to Interim) | 2025/12 | 2024/12 | 2023/12 | 2022/12 | |
| EPS (cts) | -3.000 | -- | 112.000 | -25.000 | -22.000 | -21.000 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | (0.053) | (0.426) | 0.910 | (0.238) |
| NBV per share ($) | 0.940 | -- | 0.953 | (0.128) | 0.096 | 0.265 |
| Remarks: | Real time quote last updated: 26/08/2026 18:00 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB -30,195 |
| %Change | -- |
| EPS / (LPS) | RMB -0.030 |
| NBV Per Share (¥) | RMB 0.940 |